The ESMO TAT Congress 2025 is a global meeting focuses on promising new anticancer targets and agents with a particular emphasis on those in early phase clinical development.
Download the ESMO TAT 2025 Exhibitor Manual
Contacts
Onsite Exhibition Support
ESMO TAT Congress 2025 Secretariat
ESMO Head Office
Tel: +41 (0)91 973 19 47
E-mail: meetings@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu